Journal of the National Cancer Institute
Overview
The Journal of the National Cancer Institute (JNCI) is a renowned scientific publication dedicated to advancing cancer research and knowledge. It features cutting-edge studies, reviews, and commentaries on various aspects of cancer biology, prevention, diagnosis, treatment, and survivorship. With a multidisciplinary approach, JNCI serves as a vital resource for scientists, clinicians, and policymakers in the fight against cancer.
Details
Details
Abbr.
J Natl Cancer Inst
Publisher
Oxford University Press
Start
1940
End
Continuing
Frequency
Semimonthly, <1989->
p-ISSN
0027-8874
e-ISSN
1460-2105
Country
United States
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 86
387
SJR / Ranks: 261
4986
CiteScore / Ranks: 427
18.30
JIF / Ranks: 441
10.3
Recent Articles
1.
Huang Y, Kwan M, Heckbert S, Smith N, Othus M, Laurent C, et al.
J Natl Cancer Inst
. 2025 Mar;
PMID: 40071691
Background: There are increasing concerns of cardiovascular safety related to endocrine therapy use in women with breast cancer (BC). We examined risk of cardiovascular disease (CVD) events and mortality associated...
2.
Ho M, Wang L, Wong J, Xin G, Zhang Q, Lin Y, et al.
J Natl Cancer Inst
. 2025 Mar;
PMID: 40071688
Background: Cancer-related cognitive impairment is a common complication of cancer and its treatment. The effectiveness of Traditional Chinese Medicine (TCM)-based interventions in improving subjective and objective cognitive function has not...
3.
Adcock R, Wheeler C, Hunt W, Torrez-Martinez N, Robertson M, McDonald R, et al.
J Natl Cancer Inst
. 2025 Mar;
PMID: 40069924
Background: Following human papillomavirus (HPV) vaccine introduction, declines in the prevalence of HPV vaccine types have been observed in screening cytology, but data from the United States describing HPV type-specific...
4.
Sannigrahi M, Raghav L, Rich D, Schrank T, Califano J, Lukens J, et al.
J Natl Cancer Inst
. 2025 Mar;
PMID: 40069922
Background: Limited understanding of the biology predisposing certain human papillomavirus-related (HPV+) oropharyngeal squamous cell carcinomas (OPSCCs) to relapse impedes therapeutic personalization. We aimed to identify molecular traits that distinguish recurrence-prone...
5.
Kapur P, Zhong H, Christie A, Xu H, Cai Q, Araj E, et al.
J Natl Cancer Inst
. 2025 Mar;
PMID: 40065697
The mechanisms underlying metastatic latency in renal cell carcinoma (RCC) remain poorly understood. This study evaluated two large independent cohorts for differences in tumor biology between patients who developed metastases...
6.
Nogueira L, Yabroff K, Yates E, Shultz J, Valdez R, Nori-Sarma A
J Natl Cancer Inst
. 2025 Mar;
PMID: 40064312
Background: Wildfires pose substantial health and safety threats to patients recovering from lung cancer surgery. Without specific disaster preparedness guidelines, surgical oncologists might resort to improvisational strategies, such as extending...
7.
Woodward E, Kilday J, Ng S, Kelsey A, Evans D
J Natl Cancer Inst
. 2025 Mar;
PMID: 40059635
Li Fraumeni Syndrome (LFS) arising from germline TP53 mutation results in defective DNA repair and increased risk of multiple primary cancers beginning in childhood. Curative intent radiotherapy is often used...
8.
Owens L, Fung A, Shuhendler J, Glick J, Ryser M, Gulati R, et al.
J Natl Cancer Inst
. 2025 Mar;
PMID: 40040586
Background: Recent increases in the diagnosis of certain cancers among younger individuals are generating intense concern. Many studies attribute the increase in so-called "young-onset" cancer to an etiologic cause but...
9.
10.
Holmgren A, Apathy N, Crews J, Shanafelt T
J Natl Cancer Inst
. 2025 Mar;
PMID: 40037649
Background: Electronic health record (EHR) burden is an important driver of the ongoing physician burnout crisis. EHR-based messaging (also known as inbox) in particular, including messages from patients, is associated...